Eric E. Swayze
186Patents
37h-index
100Co-inventors
93Inventor score
Filing activity: May 12, 1998 → Nov 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7399845B2 | 6-modified bicyclic nucleic acid analogs | Emerging Cross-Sectional Technologies | 471 | Active |
| US7741457B2 | 6-modified bicyclic nucleic acid analogs | Emerging Cross-Sectional Technologies | 316 | Active |
| US7696345B2 | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation | Chemistry; Metallurgy | 299 | Expired |
| US7547684B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 283 | Active |
| US7569686B1 | Compounds and methods for synthesis of bicyclic nucleic acid analogs | Chemistry; Metallurgy | 262 | Active |
| US7666854B2 | Bis-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 234 | Active |
| US8501805B2 | Substituted alpha-L-bicyclic nucleosides | Chemistry; Metallurgy | 179 | Active |
| US8546556B2 | Carbocyclic alpha-L-bicyclic nucleic acid analogs | Chemistry; Metallurgy | 176 | Active |
| US8530640B2 | Bicyclic cyclohexitol nucleic acid analogs | Chemistry; Metallurgy | 155 | Active |
| US8124745B2 | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation | Chemistry; Metallurgy | 141 | Active |
| US7750131B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 132 | Active |
| US7683036B2 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs | Chemistry; Metallurgy | 130 | Expired |
| US7339051B2 | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) | Chemistry; Metallurgy | 129 | Expired |
| US8022193B2 | 6-modified bicyclic nucleic acid analogs | Emerging Cross-Sectional Technologies | 125 | Active |
| US8278425B2 | N-substituted-aminomethylene bridged bicyclic nucleic acid analogs | Chemistry; Metallurgy | 124 | Active |
| US8278283B2 | 6-disubstituted or unsaturated bicyclic nucleic acid analogs | Chemistry; Metallurgy | 119 | Active |
| US8030467B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 118 | Active |
| US8278426B2 | Carbocyclic bicyclic nucleic acid analogs | Chemistry; Metallurgy | 118 | Active |
| US9012421B2 | Bicyclic cyclohexose nucleic acid analogs | Chemistry; Metallurgy | 114 | Active |
| US7541344B2 | Modulation of survivin expression | Chemistry; Metallurgy | 112 | Expired |
| US8268980B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 110 | Active |
| US9005906B2 | Tetrahydropyran nucleic acid analogs | Emerging Cross-Sectional Technologies | 106 | Active |
| US9127276B2 | Conjugated antisense compounds and their use | Chemistry; Metallurgy | 106 | Active |
| US8088746B2 | Bis-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 105 | Active |
| US7875733B2 | Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation | Emerging Cross-Sectional Technologies | 101 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.